Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

PROMUS PREMIER™ China Post-Approval Study

NCT: NCT03273023 · COMPLETED

NCT IDNCT03273023
StatusCOMPLETED
Start Date2018-01-11
Completion2025-10-03
SponsorBoston Scientific Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

To compile real-world clinical outcome data for the Promus PREMIERTM Everolimus-Eluting Platinum Chromium Coronary Stent System (Promus PREMIERTM Stent System) in routine clinical practice in China.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑